SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721,310 | +9.1% | 3,400 | -1.0% | 0.01% | +20.0% |
| Q2 2023 | $661,100 | +95022.3% | 3,435 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $695 | +55.5% | 3,435 | -1.2% | 0.01% | +25.0% |
| Q4 2022 | $447 | -100.0% | 3,475 | -78.1% | 0.00% | -77.8% |
| Q3 2022 | $2,169,000 | -19.7% | 15,875 | +4.0% | 0.02% | -25.0% |
| Q2 2022 | $2,702,000 | +22.9% | 15,269 | 0.0% | 0.02% | +60.0% |
| Q1 2022 | $2,199,000 | -14.9% | 15,269 | -20.5% | 0.02% | -21.1% |
| Q4 2021 | $2,585,000 | -29.2% | 19,215 | -10.7% | 0.02% | -13.6% |
| Q3 2021 | $3,653,000 | +158.9% | 21,514 | +140.7% | 0.02% | +144.4% |
| Q2 2021 | $1,411,000 | -63.8% | 8,939 | -68.1% | 0.01% | -64.0% |
| Q1 2021 | $3,893,000 | +31.2% | 28,039 | +65.5% | 0.02% | +31.6% |
| Q4 2020 | $2,967,000 | -14.8% | 16,939 | -4.8% | 0.02% | -32.1% |
| Q3 2020 | $3,483,000 | – | 17,799 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |